Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation
- PMID: 15764591
- DOI: 10.1093/glycob/cwi053
Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation
Abstract
The products of nonenzymatic glycation and oxidation of proteins and lipids, the advanced glycation end products (AGEs), accumulate in a wide variety of environments. AGEs may be generated rapidly or over long times stimulated by a range of distinct triggering mechanisms, thereby accounting for their roles in multiple settings and disease states. A critical property of AGEs is their ability to activate receptor for advanced glycation end products (RAGE), a signal transduction receptor of the immunoglobulin superfamily. It is our hypothesis that due to such interaction, AGEs impart a potent impact in tissues, stimulating processes linked to inflammation and its consequences. We hypothesize that AGEs cause perturbation in a diverse group of diseases, such as diabetes, inflammation, neurodegeneration, and aging. Thus, we propose that targeting this pathway may represent a logical step in the prevention/treatment of the sequelae of these disorders.
Similar articles
-
Role of advanced glycation end products in cellular signaling.Redox Biol. 2014 Jan 9;2:411-29. doi: 10.1016/j.redox.2013.12.016. eCollection 2014. Redox Biol. 2014. PMID: 24624331 Free PMC article. Review.
-
Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.Atherosclerosis. 2008 Jan;196(1):9-21. doi: 10.1016/j.atherosclerosis.2007.07.025. Epub 2007 Sep 10. Atherosclerosis. 2008. PMID: 17826783 Review.
-
Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses.Circulation. 2002 Feb 19;105(7):816-22. doi: 10.1161/hc0702.104183. Circulation. 2002. PMID: 11854121
-
Glycation & the RAGE axis: targeting signal transduction through DIAPH1.Expert Rev Proteomics. 2017 Feb;14(2):147-156. doi: 10.1080/14789450.2017.1271719. Epub 2016 Dec 22. Expert Rev Proteomics. 2017. PMID: 27967251 Free PMC article. Review.
-
Unlocking the biology of RAGE in diabetic microvascular complications.Trends Endocrinol Metab. 2014 Jan;25(1):15-22. doi: 10.1016/j.tem.2013.08.002. Epub 2013 Sep 3. Trends Endocrinol Metab. 2014. PMID: 24011512 Free PMC article. Review.
Cited by
-
Phytochemical constituents of Mongolian traditional medicinal plants, Chamaerhodos erecta and C. altaica, and its constituents prevents the extracellular matrix degradation factors.J Nat Med. 2013 Oct;67(4):867-75. doi: 10.1007/s11418-013-0748-1. Epub 2013 Feb 9. J Nat Med. 2013. PMID: 23397240
-
The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation.PLoS One. 2016 Sep 14;11(9):e0161715. doi: 10.1371/journal.pone.0161715. eCollection 2016. PLoS One. 2016. PMID: 27627677 Free PMC article.
-
Corn silk (Stigma maydis) in healthcare: a phytochemical and pharmacological review.Molecules. 2012 Aug 13;17(8):9697-715. doi: 10.3390/molecules17089697. Molecules. 2012. PMID: 22890173 Free PMC article. Review.
-
Inhibition and breaking of advanced glycation end-products (AGEs) with bis-2-aminoimidazole derivatives.Tetrahedron Lett. 2015;56(23):3406-3409. doi: 10.1016/j.tetlet.2015.01.122. Tetrahedron Lett. 2015. PMID: 26146419 Free PMC article.
-
Protection effect of endomorphins on advanced glycation end products induced injury in endothelial cells.J Diabetes Res. 2013;2013:105780. doi: 10.1155/2013/105780. Epub 2013 Apr 8. J Diabetes Res. 2013. PMID: 23671848 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
